About Matt Byron

Matt Byron is a partner in Ropes & Gray LLP’s strategic M&A group and focuses his practice on representing public and private companies as well as private equity sponsors in a broad range of life sciences, pharma, medtech and other healthcare transactions, including large-cap and middle-market acquisitions, divestitures, joint ventures, carve-out transactions, options to acquire, and collaborations. Matt has led recent transactions for Janssen Pharmaceuticals, Vertex Pharmaceuticals, Regeneron, Ginkgo Bioworks, DePuy Synthes, J&J Medtech, Fibrogen, and Biogen.

Contributions to Global Practice Guide

Life Sciences Trends and Developments in USA

}

Chambers and Partners make no representation or endorsement of the quality and services supplied by companies or firms that may be found on this website. In no event will Chambers and Partners be liable for any damages including, without limitation, indirect or consequential damages, or any damages whatsoever arising from use or loss of use, data, or profits, whether in action of contract, negligence or other tort action, arising out of or in connection with the use of the website.